Global Recombinant Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Global Recombinant Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

The global Recombinant Influenza Vaccine market size is expected to reach $ 190 million by 2029, rising at a market growth of 8.1% CAGR during the forecast period (2023-2029).

A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.

Recombinant technology plays an important role in the preparation of influenza vaccines. It allows scientists to create and express specific influenza virus proteins through genetic engineering to prepare influenza vaccines. This approach typically involves inserting the genetic sequence of the influenza virus into an expression system, enabling it to produce viral antigen proteins, and then using these proteins to prepare a vaccine.

This report studies the global Recombinant Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Recombinant Influenza Vaccine total production and demand, 2018-2029, (K Units)

Global Recombinant Influenza Vaccine total production value, 2018-2029, (USD Million)

Global Recombinant Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Recombinant Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Recombinant Influenza Vaccine domestic production, consumption, key domestic manufacturers and share

Global Recombinant Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Recombinant Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Recombinant Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Recombinant Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Influenza Vaccine market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Influenza Vaccine Market, Segmentation by Type
Vial
Prefilled

Global Recombinant Influenza Vaccine Market, Segmentation by Application
Public Sector
Private Sector

Companies Profiled:
Sanofi

Key Questions Answered

1. How big is the global Recombinant Influenza Vaccine market?

2. What is the demand of the global Recombinant Influenza Vaccine market?

3. What is the year over year growth of the global Recombinant Influenza Vaccine market?

4. What is the production and production value of the global Recombinant Influenza Vaccine market?

5. Who are the key producers in the global Recombinant Influenza Vaccine market?